Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-1-30
pubmed:abstractText
The identification of malignant cells in effusions by conventional cytology is hampered by its limited sensitivity. The aim of this study was to improve tumor cell detection in effusions by molecular approaches.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
474-83
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:14752070-Aneuploidy, pubmed-meshheading:14752070-Ascitic Fluid, pubmed-meshheading:14752070-Cytological Techniques, pubmed-meshheading:14752070-Epithelial Cells, pubmed-meshheading:14752070-Female, pubmed-meshheading:14752070-Humans, pubmed-meshheading:14752070-In Situ Hybridization, Fluorescence, pubmed-meshheading:14752070-Male, pubmed-meshheading:14752070-Mammaglobin A, pubmed-meshheading:14752070-Neoplasm Proteins, pubmed-meshheading:14752070-Neoplasms, pubmed-meshheading:14752070-Pleural Effusion, Malignant, pubmed-meshheading:14752070-RNA, Messenger, pubmed-meshheading:14752070-RNA, Neoplasm, pubmed-meshheading:14752070-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:14752070-Sensitivity and Specificity, pubmed-meshheading:14752070-Tumor Markers, Biological, pubmed-meshheading:14752070-Uteroglobin
pubmed:year
2004
pubmed:articleTitle
Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
pubmed:affiliation
Department of Internal Medicine, Division of Hematology and Oncology, Innsbruck University Hospital, Anichstrasse 35, A-6020 Innsbruck, Austria. michael.fiegl@uibk.ac.at
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't